✦ LIBER ✦

Cisplatin and doxorubicin. An effective chemotherapy combination in the treatment of advanced basal cell and squamous carcinoma of the skin

✍ Scribed by Troy H. Guthrie Jr.; Leland J. McElveen; Edward S. Porubsky; John D. Harmon

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 333 KB
Volume: 55
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19850415)55:8<1629::aid-cncr2820550802>3.0.co;2-i

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of advanced squamous cell carc

Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin

✍ Hussein Sadek; Nacer Azli; Jean Louis Wendling; Esteban Cvitkovic; Mohamed Rahal 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB 👁 2 views

Cisplatin and 5-fluorouracil for advance

Cisplatin and 5-fluorouracil for advanced locoregional and metastatic squamous cell carcinoma of the skin

✍ Tawfiq Khansur; Alan Kennedy 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 2 views

Seven patients with advanced locoregional or metastatic squamous cell carcinoma of the skin were treated with cis-daimminedichloroplatin (cisplatin) and 5fluorouracil(5-FU). Responses were seen in six of seven patients (three partial responses [PR] and three complete responses [CR]). One patient is

Paclitaxel, 5-fluorouracil, and cisplati

Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma

✍ Yeul H. Kim; Sang W. Shin; Byung S. Kim; Jin H. Kim; Jong G. Kim; Young J. Mok; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Background: Although the clinical efficacy of paclitaxel in the treatment of gastric carcinoma has not been clearly defined, recent reports have suggested a possible role in the treatment of upper gastrointestinal carcinomas in vitro and in vivo. in this study, the authors evaluated the efficacy

Cisplatin and 5-fluorouracil chemotherap

Cisplatin and 5-fluorouracil chemotherapy in advanced or recurrent squamous cell carcinoma of the head and neck

✍ Richard J. Mercier; G. David Neal; Douglas E. Mattox; George A. Gates; Thomas C. 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB 👁 2 views

Combination chemotherapy with methotrexa

Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck

✍ M. Clavel; F. Cognetti; P. Dodion; J. Wildiers; R. Rosso; A. Rossi; B. Gignoux; 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 2 views

## For the EORTC Head and Neck Cooperative Group A total of 185 eligible patients with advanced inoperable squamous cell carcinoma of the head and neck were randomized into two groups; the cisplatin, methotrexate, bleomycin, and vincristine (CABO) group received cisplatin (50 mg/m2; day 4), methot

Mitotane associated with etoposide, doxo

Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma

✍ Alfredo Berruti; Massimo Terzolo; Anna Pia; Alberto Angeli; Luigi Dogliotti 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

BACKGROUND. The use of either mitotane or chemotherapy in the treatment of advanced adrenocortical carcinoma (ACC) has led to scanty and controversial results. The recent finding that mitotane is able to reverse in vitro multidrug resistance has provided a rational basis for combining this agent wit